Glyxambi Lawsuit
What is the Glyxambi Lawsuit?
Glyxambi is a prescription medication used to treat type 2 diabetes. It is a combination of two drugs, empagliflozin and linagliptin. Empagliflozin is an SGLT2 inhibitor, which works by causing the kidneys to excrete excess glucose in the urine. Linagliptin is a DPP-4 inhibitor, which works by increasing the amount of insulin produced by the pancreas.
In 2015, the FDA approved Glyxambi for use in the United States. However, since then, there have been numerous reports of serious side effects associated with the drug, including:
- Diabetic ketoacidosis (DKA)
- Kidney failure
- Heart attack
- Stroke
- Death
In response to these reports, the FDA has ordered the manufacturers of SGLT2 inhibitors, including Glyxambi, to conduct further testing to determine the safety risks of these drugs.
Who is Eligible to File a Glyxambi Lawsuit?
If you took Glyxambi and suffered serious side effects, you may be eligible to file a lawsuit against the manufacturers of the drug. To be eligible, you must meet the following criteria:
- You must have taken Glyxambi as prescribed by your doctor.
- You must have suffered a serious side effect, such as DKA, kidney failure, heart attack, stroke, or death.
- Your side effect must be causally linked to taking Glyxambi.
What Damages Can I Recover in a Glyxambi Lawsuit?
If you are successful in your Glyxambi lawsuit, you may be able to recover damages for the following:
- Medical expenses
- Lost wages
- Pain and suffering
- Emotional distress
- Punitive damages
How Do I File a Glyxambi Lawsuit?
If you are considering filing a Glyxambi lawsuit, you should contact an experienced product liability attorney. An attorney can review your case and advise you on your legal options.
FAQs:
Q: What are the most common side effects of Glyxambi?
A: The most common side effects of Glyxambi are mild and go away on their own. These side effects can include urinary tract infections, yeast infections, and skin reactions.
Q: What are the serious side effects of Glyxambi?
A: The serious side effects of Glyxambi include diabetic ketoacidosis (DKA), kidney failure, heart attack, stroke, and death.
Q: Am I eligible to file a Glyxambi lawsuit?
A: To be eligible to file a Glyxambi lawsuit, you must have taken Glyxambi as prescribed by your doctor and suffered a serious side effect, such as DKA, kidney failure, heart attack, stroke, or death.
Q: What damages can I recover in a Glyxambi lawsuit?
A: If you are successful in your Glyxambi lawsuit, you may be able to recover damages for medical expenses, lost wages, pain and suffering, emotional distress, and punitive damages.
Q: How do I file a Glyxambi lawsuit?
A: To file a Glyxambi lawsuit, you should contact an experienced product liability attorney.
Q: How long does it take to settle a Glyxambi lawsuit?
A: The amount of time it takes to settle a Glyxambi lawsuit will vary depending on the facts of the case and the willingness of the parties to negotiate. However, most lawsuits settle within one to two years of being filed.
Conclusion
If you have taken Glyxambi and suffered serious side effects, you may be eligible to file a lawsuit against the manufacturers of the drug. To learn more about your legal options, you should contact an experienced product liability attorney.
References:
- FDA Safety Alert on SGLT2 Inhibitors: https://www.fda.gov/drugs/drug-safety-and-availability/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious
- Glyxambi Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206073s000lbl.pdf
- Glyxambi Lawsuit Information: https://www.impactlaw.com/dangerous-drugs/sglt2-inhibitors/glyxambi
Sources
What is the Glyxambi Lawsuit? Glyxambi is a prescription medication used to treat type 2 diabetes. It is a combination of two drugs, empagliflozin and linagliptin. Empagliflozin is an SGLT2 inhibitor, which works by causing the kidneys to excrete excess glucose in the urine. Linagliptin is a DPP-4 inhibitor, which works by increasing the amount…